ScholarLens Back to search
2008•Modern Medicine HealthRequires access

Observation on the curative effects of compound danshendiwan and isosorbide dinitrate in stable angina pectoris in patients with coronary heart disease

Yue Xiao-chun

Open publisher page 0 citations

Abstract

Objective:To investigate the curative effect of compound danshendiwan in the treatment of stable angina pectoris in patients with coronary heart disease.Methods:The treatment group was treated with compound danshendiwan,while the control group with isosorbide dinitrate.The remittent condition of angina pectoris and improvement condition of ECG in two groups were observed and compared respectively after treatment.Results:The effectual rate was 69% in the treatment group and 51% in the control group,with significant difference between two groups(P0.05);The total effective rate of ECT ST-T segment normalization was 65.4% in the treatment group and 52.8% in the control group,with significant difference between them(P0.01).Conclusion:Compound danshendiwan is a relatively ideal and safe drug for the treatment of stable angina pectoris in patients with coronary heart disease.

About this research paper

What this paper is about

Objective:To investigate the curative effect of compound danshendiwan in the treatment of stable angina pectoris in patients with coronary heart disease.Methods:The treatment group was treated with compound danshendiwan,while the control group with isosorbide dinitrate.The remittent condition of angina pectoris and improvement condition of ECG in two groups were observed and compared respectively after treatment.Results:The effectual rate was 69% in the treatment group and 51% in the control group,with significant difference between two groups(P0.05);The total effective rate of ECT ST-T segment normalization was 65.4% in the treatment group and 52.8% in the control group,with significant difference between them(P0.01).Conclusion:Compound danshendiwan is a relatively ideal and safe drug for the treatment of stable angina pectoris in patients with coronary heart disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the curative effect of compound danshendiwan in the treatment of stable angina pectoris in patients with coronary heart disease.Methods:The treatment group was treated with compound danshendiwan,while the control group with isosorbide dinitrate.The remittent condition of angina pectoris and improvement condition of ECG in two groups were observed and compared respectively after treatment.Results:The effectual rate was 69% in the treatment group and 51% in the control group,with significant difference between two groups(P0.05);The total effective rate of ECT ST-T segment normalization was 65.4% in the treatment group and 52.8% in the control group,with significant difference between them(P0.01).Conclusion:Compound danshendiwan is a relatively ideal and safe drug for the treatment of stable angina pectoris in patients with coronary heart disease.

Key concepts: Medicine, Isosorbide dinitrate, Angina, Internal medicine, Cardiology, Stable angina, Coronary heart disease, Significant difference

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Observation on the curative effects of compound danshendiwan and isosorbide dinitrate in stable angina pectoris in patients with coronary heart disease — Research Paper | ScholarLens